Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
British Journal of Cancer|December 1, 2011
Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastasesR Bartsch, A Berghoff, U Pluschnig, et al.
Breast Cancer Research and Treatment|April 25, 2016
Prognostic impact of breast cancer subtypes in elderly patientsE S Bergen, C Tichy, A S Berghoff, et al.
European Journal of Cancer Care|May 11, 2017
Decreased body mass index is associated with impaired survival in lung cancer patients with brain metastases: A retrospective analysis of 624 patientsE K Masel, A S Berghoff, L M Füreder, et al.
British Journal of Cancer|October 1, 2014
Selecting first-line bevacizumab-containing therapy for advanced breast cancer: TURANDOT risk factor analysesT Brodowicz, I Lang, Z Kahan, et al.
Leukemia|May 24, 2016
Next-generation sequencing identifies major DNA methylation changes during progression of Ph+ chronic myeloid leukemiaG Heller, T Topakian, C Altenberger, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2022
Dabrafenib plus trametinib in patients with BRAF V600E-mutant anaplastic thyroid cancer: updated analysis from the phase II ROAR basket studyV Subbiah, R J Kreitman, Z A Wainberg, et al.
British Journal of Cancer|January 12, 2012
Brain metastases free survival differs between breast cancer subtypesA Berghoff, Z Bago-Horvath, C De Vries, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 20, 2013
Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industryR Bartsch, S Frings, M Marty, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 18, 2009
Third consensus on medical treatment of metastatic breast cancerS Beslija, J Bonneterre, H J Burstein, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 19, 2013
Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)G G Steger, R Greil, A Lang, et al.
Pageof 16